Petr Brabec

1.5k total citations
26 papers, 350 citations indexed

About

Petr Brabec is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Petr Brabec has authored 26 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Hematology. Recurrent topics in Petr Brabec's work include Hemophilia Treatment and Research (6 papers), Platelet Disorders and Treatments (4 papers) and Muscle Physiology and Disorders (4 papers). Petr Brabec is often cited by papers focused on Hemophilia Treatment and Research (6 papers), Platelet Disorders and Treatments (4 papers) and Muscle Physiology and Disorders (4 papers). Petr Brabec collaborates with scholars based in Czechia, United Kingdom and Denmark. Petr Brabec's co-authors include Ladislav Dušek, Tomáš Büchler, Rostislav Vyzula, Bohuslav Melichar, Miroslav Penka, Jitka Abrahámová, Peter Salaj, Petr Cetkovský, Ulla Hedner and Jakub Gregor and has published in prestigious journals such as Annals of Oncology, BMC Public Health and Journal of Nuclear Materials.

In The Last Decade

Petr Brabec

20 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petr Brabec Czechia 12 160 105 102 67 48 26 350
Marie Laure Tanguy France 7 54 0.3× 60 0.6× 58 0.6× 83 1.2× 39 0.8× 8 404
Dennis Göerlich Germany 5 119 0.7× 82 0.8× 182 1.8× 52 0.8× 14 0.3× 11 427
Daisuke Yasui Japan 10 116 0.7× 32 0.3× 13 0.1× 28 0.4× 71 1.5× 48 289
L K Rajeev India 9 59 0.4× 24 0.2× 35 0.3× 20 0.3× 117 2.4× 63 224
K. Tan Canada 8 160 1.0× 57 0.5× 29 0.3× 38 0.6× 15 0.3× 23 343
Kei Asukai Japan 11 140 0.9× 42 0.4× 21 0.2× 84 1.3× 155 3.2× 36 385
Patrick Nierlich Austria 11 299 1.9× 47 0.4× 27 0.3× 17 0.3× 42 0.9× 27 423
Hui‐Li Gan China 10 197 1.2× 46 0.4× 12 0.1× 40 0.6× 37 0.8× 24 305
S Munkvad Denmark 11 92 0.6× 27 0.3× 120 1.2× 74 1.1× 7 0.1× 23 312
Christos Christopoulos United Kingdom 9 56 0.3× 34 0.3× 32 0.3× 17 0.3× 44 0.9× 17 280

Countries citing papers authored by Petr Brabec

Since Specialization
Citations

This map shows the geographic impact of Petr Brabec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Brabec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Brabec more than expected).

Fields of papers citing papers by Petr Brabec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Brabec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Brabec. The network helps show where Petr Brabec may publish in the future.

Co-authorship network of co-authors of Petr Brabec

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Brabec. A scholar is included among the top collaborators of Petr Brabec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Brabec. Petr Brabec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palmieri, Lola‐Jade, Tomáš Büchler, Antoine Meyer, et al.. (2022). Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis. Cancers. 14(6). 1410–1410.
2.
Juráček, Jaroslav, Alexandr Poprach, Jindřich Kopecký, et al.. (2019). MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients. Cancer Genomics & Proteomics. 16(5). 353–359. 17 indexed citations
3.
Kocáková, Ilona, Ivo Kocák, Andrea Jurečková, et al.. (2015). Long term experience of patients with unresectable or metastatic KIT positive gastrointestinal stromal tumours. Bratislavské lekárske listy/Bratislava medical journal. 116(4). 218–221. 2 indexed citations
4.
Strenková, Jana, et al.. (2014). REaDY - český registr svalových dystrofií. Česká a slovenská neurologie a neurochirurgie. 77(2). 2 indexed citations
5.
Jansa, Pavel, Jiří Jarkovský, Hikmet Al‐Hiti, et al.. (2014). Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. BMC Pulmonary Medicine. 14(1). 45–45. 53 indexed citations
6.
Švancara, Jan, et al.. (2013). Vyhodnocení sběru epidemiologických dat u cévních mozkových příhod z registru IKTA. Incidence cévních mozkových příhod v okrese Zlín. Česká a slovenská neurologie a neurochirurgie. 76(2). 1 indexed citations
7.
8.
Voháňka, Stanislav, et al.. (2012). S.P.34 ReaDY: The Czech national registry of myotonic disorders. Neuromuscular Disorders. 22(9-10). 881–882.
9.
Poprach, Alexandr, Zbyněk Bortlíček, Tomáš Büchler, et al.. (2012). Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database. Medical Oncology. 29(5). 3314–3320. 25 indexed citations
10.
11.
Büchler, Tomáš, Bohuslav Melichar, Petr Brabec, et al.. (2011). Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry. Annals of Oncology. 23(2). 395–401. 57 indexed citations
12.
Blatný, Jan, Petra Ovesná, Petr Brabec, et al.. (2010). [Recombinant activated factor VII in the treatment of life threatening post-partum haemorrhage; registry UniSeven in the Czech Republic].. PubMed. 75(4). 297–305.
13.
Chojnowski, Krzysztof, Anna Klukowska, Magdalena Łętowska, et al.. (2010). Registry of inherited bleeding disorders in Poland – current status and potential role of the HemoRec database. Haemophilia. 17(1). e189–95. 13 indexed citations
14.
Brabec, Petr, et al.. (2009). Characterization of the DMD/BMD patient population in Czech Republic and Slovakia using an innovative registry approach. Neuromuscular Disorders. 19(4). 250–254. 12 indexed citations
15.
16.
Puetz, John, et al.. (2009). Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. Pediatric Blood & Cancer. 53(6). 1074–1078. 13 indexed citations
17.
Brabec, Petr, Jozef Šufliarský, Zdeněk Linke, et al.. (2009). A whole population study of gastrointestinal stromal tumors in the Czech Republic and Slovakia. Neoplasma. 56(5). 459–464. 19 indexed citations
18.
Salaj, Peter, Petr Brabec, Miroslav Penka, et al.. (2009). Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic. Haemophilia. 15(3). 752–759. 59 indexed citations
19.
Jarkovský, Jiří, et al.. (2006). Information System of ARROW Project: Assessment of Ecological State of Surface Waters. EnviroInfo. 353–360.
20.
Dušek, Ladislav, et al.. (2005). The National Web Portal for Cancer Epidemiology in the Czech Republic.. EnviroInfo. 434–439. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Laure Tanguy Breakdown of academic impact, for papers by Dennis Göerlich Breakdown of academic impact, for papers by Daisuke Yasui Breakdown of academic impact, for papers by L K Rajeev Breakdown of academic impact, for papers by K. Tan Breakdown of academic impact, for papers by Kei Asukai Breakdown of academic impact, for papers by Patrick Nierlich Breakdown of academic impact, for papers by Hui‐Li Gan Breakdown of academic impact, for papers by S Munkvad Breakdown of academic impact, for papers by Christos Christopoulos
Rankless by CCL
2026